Nuclear Regulatory Commission December 1, 2021 – Federal Register Recent Federal Regulation Documents

The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 15, 2021 to discuss the NRC staff's draft Alpha Tau Alpha DartTM Manual Brachytherapy Licensing Guidance and the ACMUI Subcommittee on Alpha Dart draft report on the proposed draft licensing guidance; the NRC staff's draft additional licensing considerations memo for CivaTech Oncology Inc.'s CivaDermTM and the ACMUI Subcommittee ACMUI Subcommittee on Civaderm draft report on the proposed draft memo; the NRC staff's draft revision of Regulatory Guide 8.39, ``Release of Patients Administered Radioactive Material and the ACMUI Subcommittee on Regulatory Guide 8.39, ``Release of Patients Administered Radioactive Material'' draft report on the proposed draft revision of the regulatory guide. The meeting agenda is subject to change. The current agenda and any updates will be available on the ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings / 2021.html or by emailing Mr. Don Lowman at the contact information below.